A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy

NCT00001894 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
70
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)